Pharmaceutical companies Mylan (NAS: MYL) and Watson Pharmaceuticals (NYS: WPI) have announced that they have received FDA approval for generic versions of Pfizer's (NYS: PFE) Revatio, a drug used to ...

Another drug in Pfizer’s (PFE) portfolio started facing generic competition recently. Generic competition for Pfizer’s pulmonary arterial hypertension (:PAH) drug, Revatio (sildenafil) tablets has ...

Sildenafil 10mg/mL; pwd for oral susp after reconstitution; grape flavor; contains sorbitol. Pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay ...

An attempt by Pfizer to extend the uses of its pulmonary artery hypertension (PAH) drug Revatio into a new paediatric indication has had a major setback. Revatio (sildenafil citrate) – which is based ...

Please provide your email address to receive an email when new articles are posted on . The FDA today released a statement clarifying its previous recommendation related to the prescription of ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. announced that Revatio ® (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years old with ...

(Reuters) – U.S. health regulators recommended against use of Pfizer Inc’s pulmonary arterial hypertension (PAH) drug Revatio in children up to 17 years of age, saying it had a higher risk of death ...

Consumer Reports has no relationship with any advertisers on this website. If you’re looking for a less costly Viagra, you might want to ask your doctor about sildenafil. It's the active ingredient in ...